Orientation-dependent and sequence-specific expansions of CTG/CAG trinucleotide repeats in <em>Saccharomyces cerevisiae</em>
Abstract
A quantitative and selective genetic assay was developed to monitor expansions of trinucleotide repeats (TNRs) in yeast. A promoter containing 25 repeats allows expression of a URA3 reporter gene and yields sensitivity to the drug 5-fluoroorotic acid. Expansion of the TNR to 30 or more repeats turns off URA3 and provides drug resistance. When integrated at either of two chromosomal loci, expansion rates were 1 × 10 to 4 × 10 per generation if CTG repeats were replicated on the lagging daughter strand. PCR analysis indicated that 5–28 additional repeats were present in 95% of the expanded alleles. No significant changes in CTG expansion rates occurred in strains deficient in the mismatch repair gene MSH2 or the recombination gene RAD52. The frequent nature of CTG expansions suggests that the threshold number for this repeat is below 25 in this system. In contrast, expansions of the complementary repeat CAG occurred at 500- to 1,000-fold lower rates, similar to a randomized (C,A,G) control sequence. When the reporter plasmid was inverted within the chromosome, switching the leading and lagging strands of replication, frequent expansions were observed only when CTG repeats resided on the lagging daughter strand. Among the rare CAG expansions, the largest gain in tract size was 38 repeats. The control repeats CTA and TAG showed no detectable rate of expansions. The orientation-dependence and sequence-specificity data support the model that expansions of CTG and CAG tracts result from aberrant DNA replication via hairpin-containing Okazaki fragments.
Expansions of endogenous trinucleotide repeats (TNRs) underlie more than 10 human genetic disorders, including Huntington’s disease and myotonic dystrophy (reviewed in refs. 1 and 2). Several lines of evidence indicate that TNR alterations occur differently than for other microsatellites. For example, large increases in TNR number range from 10 to 2,000 repeats among affected kindreds (reviewed in refs. 1 and 2). Also, the propensity to undergo large TNR expansions is unaffected by the mismatch repair status of the cell (3, 4). These and other features suggest that TNR instability results from an unusual mechanism.
Although each triplet repeat disease exhibits unique genetic features (reviewed in ref. 1), there are several common aspects that provide clues to the mechanism of TNR instability. First is sequence specificity; all known TNR diseases result from expansions of the sequences CNG (where N is any nucleotide) or GAA. Second, a single genetic event is sufficient to incorporate many additional TNRs. Since the unaffected allele often is unaltered (5, 6), this suggests that repeats are added de novo by a replicational mechanism. Third, instability often is governed by a threshold number. TNR lengths below the threshold are stable whereas alleles above the threshold are prone to expansions (reviewed in ref. 1).
Examination of TNR structures suggests that DNA hairpins may play an important role in expansions. When single-stranded, a subset of TNRs forms secondary structures in vitro (7, 8). For example, 15-repeat molecules of CTG and CAG form hairpins that melt at 47° and 38°, respectively (summarized in ref. 8). Most other TNRs show no predisposition to expand and are unlikely to form stable secondary structures (7, 8). In a second corollary, duplex DNA containing CTG/CAG and CGG/CCG repeats form slipped-strand structures upon denaturation and reannealing (9), indicating that slipped structures can form in competition with duplexes. A third parallel is that hairpin formation in vitro is dictated by a threshold number of repeats. Based on modeling studies, a minimum number of repeats is important to stabilize the hairpin (7).
The noteworthy correlations between TNR genetics and formation of secondary structures such as hairpins led a number of authors to suggest that expansions result from aberrant lagging-strand DNA replication (2, 5, 10–14). As diagrammed in Fig. Fig.11A, lagging-strand DNA replication involves synthesis of ≈150- to 300-nt Okazaki fragments that subsequently are processed and ligated together. If TNR sequences such as CTG or CAG are present, hairpins could form on the lagging daughter strand. Extension of these hairpins by DNA synthesis would lead to the presence of extra triplet repeats. If unrepaired, the anomalous strand would template for an expanded second strand in the next round of DNA synthesis. The hairpin model for TNR expansions therefore predicts not only sequence specificity, with expansions arising most often from sequences that readily form hairpins, but also suggests possible orientation effects for complementary pairs such as CTG and CAG. In other words, the presence of the stronger, CTG hairpin-forming sequence on the lagging daughter strand should yield more expansions than the reciprocal case for a CAG tract.
Direct experimental proof for the hairpin model has been elusive. In transgenic mice, triplet repeats are quite stable (summarized in ref. 15). Among the alterations reported, all have been either losses or small gains. Thus, these animals have not revealed much about the mechanism of TNR expansions. In bacteria and yeast, contractions occur much more frequently than expansions (13, 16, 17). Assays that monitor TNRs by nonselective physical techniques (PCR or Southern blotting) tend to lack the sensitivity for facile detection of expansions. Sensitivity can be increased in yeast by the presence of a rad27 mutation that increases the frequency of expansions and contractions (18, 19). Under these conditions, expansions become abundant enough to detect by physical means. However, interpretation of results is complicated by the pleiotropic nature of rad27 mutations (20–22). In other experiments (19), CTG repeats were shown to act as fragile sites in yeast. Unfortunately, chromosome breakage also results in recombinational deletion of the TNR sequences, making it difficult to characterize the nature of expansions.
In this paper we describe a new genetic assay for TNR expansions in yeast that is selective and quantitative. Using this assay, we observe a number of characteristics for CTG and CAG expansions that are consistent with predictions of the hairpin model. To our knowledge, this is the most conclusive in vivo evidence supporting the hairpin-based, replicational model for CTG and CAG expansions.
(C,A,G)25 refers to a random sequence of 25 C, A, and G residues with no repeat units, as described in Methods and Materials.
Chromosomal alignment refers to the direction of URA3 relative to the chromosomal sequences (Fig. (Fig.1).1). “Forward” indicates that the URA3 reporter and the endogenous LYS2 gene are aligned in the same direction (as in Fig. Fig.11A and B), and “reverse” indicates opposite directions (Fig. (Fig.11C and D).
Acknowledgments
We thank Bonny Brewer for sharing results before publication. We also thank Richard Pelletier, Mike Rolfsmeier, Troy Luster, and Luisa Pessoa-Brandão for valuable assistance. This work was supported by a research grant from the Muscular Dystrophy Association (to R.S.L.), by a postdoctoral fellowship from the Hereditary Disease Foundation (to J.J.M.), and by National Cancer Institute Cancer Center Support Grant P30 CA36727 (to the Eppley Institute).
ABBREVIATIONS
TNR | trinucleotide repeat |
5FOA | 5-fluoroorotic acid |
References
- 1. Paulson H L, Fischbeck K H. Annu Rev Neurosci. 1996;19:79–107.[PubMed]
- 2. Wells R D. J Biol Chem. 1996;271:2875–2878.[PubMed]
- 3. Kramer P R, Pearson C E, Sinden R R. Hum Genet. 1996;98:151–157.[PubMed]
- 4. Goellner G M, Tester D, Thibodeau S, Almqvist E, Goldberg Y P, Hayden M R, McMurray C T. Am J Hum Genet. 1997;60:879–890.
- 5. McMurray C T. Chromosoma. 1995;104:2–13.[PubMed]
- 6. Gacy A M, Goellner G M, Spiro C, Chen X, Gupta G, Bradbury E M, Dyer R B, Mikesell M J, Yao J Z, Johnson A J, et al Mol Cell. 1998;1:583–593.[PubMed][Google Scholar]
- 7. Gacy A M, Goellner G, Juranic N, Macura S, McMurray C T. Cell. 1995;81:533–540.[PubMed]
- 8. Mitas M. Nucleic Acids Res. 1997;25:2245–2253.
- 9. Pearson C E, Sinden R R. Biochemistry. 1996;35:5041–5053.[PubMed]
- 10. Richards R I, Sutherland G R. Nat Genet. 1994;6:114–116.[PubMed]
- 11. Mitas M, Yu A, Dill J, Kamp T J, Chambers E J, Haworth I S. Nucleic Acids Res. 1995;23:1050–1059.
- 12. Gordenin D A, Kunkel T A, Resnick M A. Nat Genet. 1997;16:116–118.[PubMed]
- 13. Freudenreich C H, Stavenhagen J B, Zakian V A. Mol Cell Biol. 1997;17:2090–2098.
- 14. Schweitzer J K, Livingston D M. Hum Mol Genet. 1997;6:349–355.[PubMed]
- 15. La Spada A R, Peterson K R, Meadows S A, McClain M E, Jeng G, Chmelar R S, Haugen H A, Chen K, Singer M J, Moore D, et al Hum Mol Genet. 1998;7:959–967.[PubMed][Google Scholar]
- 16. Kang S, Jaworski A, Ohshima K, Wells R D. Nat Genet. 1995;10:213–218.[PubMed]
- 17. Maurer D J, O’Callaghan B L, Livingston D M. Mol Cell Biol. 1996;16:6617–6622.
- 18. Schweitzer J K, Livingston D M. Hum Mol Genet. 1998;7:69–74.[PubMed]
- 19. Freudenreich C H, Kantrow S M, Zakian V A. Science. 1998;279:853–856.[PubMed]
- 20. Sommers C H, Miller E J, Dujon B, Prakash S, Prakash L. J Biol Chem. 1995;270:4193–4196.[PubMed]
- 21. Tishkoff D X, Filosi N, Gaida G M, Kolodner R D. Cell. 1997;88:253–263.[PubMed]
- 22. Kokoska R J, Stefanovic L, Tran H T, Resnick M A, Gordenin D A, Petes T D. Mol Cell Biol. 1998;18:2779–2788.
- 23. Wu T-H, Marinus M G. J Bacteriol. 1994;176:5393–5400.
- 24. Kramer B, Kramer W, Williamson M S, Fogel S. Mol Cell Biol. 1989;9:4432–4440.
- 25. Rose M D, Winston F, Hieter P Methods in Yeast Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press; 1988. [PubMed][Google Scholar]
- 26. Schiestl R H, Gietz D. Curr Genet. 1989;16:339–346.[PubMed]
- 27. Miret J J, Pessoa-Brandao L, Lahue R S. Mol Cell Biol. 1997;17:3382–3387.
- 28. Sikorski R S, Hieter P. Genetics. 1989;122:19–27.
- 29. Lea D E, Coulson C A. J Genet. 1948;49:264–284.[PubMed]
- 30. Furter-Graves E M, Hall B D. Mol Gen Genet. 1990;223:407–416.[PubMed]
- 31. Boeke J D, Lacroute F, Fink G R. Mol Gen Genet. 1984;197:345–346.[PubMed]
- 32. Morrison A, Johnson A L, Johnston L H, Sugino A. EMBO J. 1993;12:1467–1473.
- 33. Nag D K, White M A, Petes T D. Nature (London) 1989;340:318–320.[PubMed]
- 34. Sia E A, Kokoska R J, Dominska M, Greenwell P, Petes T D. Mol Cell Biol. 1997;17:2851–2858.